Sarcoma trials in Ukraine

2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

  Where

  Cherkasy, Chernivtsi, Ivano-Frankivsk, Kiev, Kropyvnytskyi, Kryvyi Rih, Kyiv, Lutsk, Lviv, Rivne, Vinnytsia

  Age

  18 years and over

  People

  348 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06345729 · EU 2023-507776-42-00
• Phase 2Taking people
  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  Where

  Cherkasy, Ivano-Frankivsk, Kropyvnytskyi, Kryvyi Rih, Kyiv, Lviv, Uzhhorod, Vinnitsya

  Age

  18 years and over

  People

  140 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07252739 · EU 2025-521939-36-00